Adult Primary Hepatocellular Carcinoma Terminated Phase 2 Trials for Erlotinib (DB00530)

Also known as: Primary Adult Hepatocellular Carcinoma

IndicationStatusPhase
DBCOND0029159 (Adult Primary Hepatocellular Carcinoma)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00047333Erlotinib in Treating Patients With Liver Cancer That Cannot be Surgically RemovedTreatment